Secondary Logo

PrEP-RN

Clinical Considerations and Protocols for Nurse-Led PrEP

Journal of the Association of Nurses in AIDS Care: May-June 2019 - Volume 30 - Issue 3 - p e5–e6
doi: 10.1097/JNC.0000000000000092
CE TEST
Free

Instructions:

  • Read the article on page 301.
  • The test for this CE activity can be taken online at http://www.NursingCenter.com/CE/JANAC. Find the test under the article title. Tests can no longer be mailed or faxed.
  • You will need to create a username and password and login to your personal CE Planner account before taking online tests. (It’s free!) Your planner will keep track of all your Lippincott Professional Development online CE activities for you.
  • There is only one correct answer for each question. A passing score for this test is 13 correct answers. If you pass, you can print your certifi cate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost.
  • For questions, contact Lippincott Professional Development: 1-800-787-8985.

Registration Deadline: June 4, 2021

Disclosure Statement: The authors and planners have disclosed that they have no financial relationships related to this article.

Provider Accreditation:

Lippincott Professional Development will award 1.5 contact hours for this continuing nursing education activity.

LPD is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours. LPD is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida, CE Broker #50-1223.

Your certificate is valid in all states.

Payment:

• The registration fee for this test is $9.95 for members and $17.95 for nonmembers.

DOI: 10.1097/JNC.0000000000000092

Purpose: To provide information about how nurses can provide pre-exposure prophylaxis (PrEP-RN) in sexually transmitted infection (STI) clinics.

Learning Objectives/Outcomes: After completing this continuing education activity, you should be able to:

  • 1. Identify the epidemiology of HIV infection and issues related to PrEP.
  • 2. Specify how nurses can provide PrEP in an outpatient STI clinic.
  • 1. The only medication approved for PrEP in the U.S. and Canada is the fixed combination of emtricitabine (FTC) plus tenofovir disoproxil fumarate (TDF) in which doses?
    • a. 200 mg FTC + 150 mg TDF
    • b. 300 mg FTC + 200 mg TDF
    • c. 400 mg FTC + 250 mg TDF
  • 2. In the 2015 study by Pathela et al., more than 1 in 20 men were diagnosed with HIV within 1 year of a diagnosis of
    • a. syphilis.
    • b. chlamydia.
    • c. human papillomavirus.
  • 3. According to the Centers for Disease Control and Prevention (2018), the rates of HIV acquisition are higher in what group compared to other populations that are affected by HIV?
    • a. transgender persons
    • b. men who have sex with men (MSM)
    • c. persons who share injection drug paraphernalia
  • 4. In the U.S. in 2016, the rate of HIV infection among women in which ethnic communities was disproportionately higher than for females of other ethnicities?
    • a. Native American, Alaskan Native, and Native Hawaiian
    • b. Hispanic, Latina
    • c. African, Caribbean, Black
  • 5. According to the PrEP-RN model described in this article, persons who should be actively offered PrEP include all of the following except
    • a. anyone after post-exposure prophylaxis (PEP) use.
    • b. persons from global endemic areas.
    • c. MSM with rectal gonorrhea.
  • 6. A targeted approach recommended by the authors to increase PrEP awareness is
    • a. using mass media strategies.
    • b. placing brochures in public restrooms.
    • c. educating staff in STI clinics about PrEP.
  • 7. At the first clinic visit, the authors note that patients should be assessed for symptoms of acute HIV infection that they have at the visit and in the preceding 4 weeks, such as
    • a. myalgias.
    • b. nonproductive cough.
    • c. conjunctivitis.
  • 8. Known contraindications to FTC/TDF include
    • a. estimated glomerular filtration rate (eGFR) > 60 mL/min.
    • b. elevated liver enzyme levels.
    • c. HIV-positive status.
  • 9. Serology testing at the first clinic visit includes testing for
    • a. gonorrhea.
    • b. chlamydia.
    • c. hepatitis A, B, and C.
  • 10. According to the PrEP-RN model, what laboratory test is used to calculate an eGFR?
    • a. albumin
    • b. creatinine
    • c. blood urea nitrogen
  • 11. The model used in this article calculates the eGFR using the more accurate
    • a. Chronic Kidney Disease Epidemiology (CKD-Epi) Collaboration formula.
    • b. Cockcroft-Gault formula.
    • c. Modification of Diet in Renal Disease (MDRD) Study formula.
  • 12. Risk reduction counseling for patients who will be starting PrEP include all of the following except the
    • a. use of PEP for missed FTC/TDF doses.
    • b. fact that PrEP is effective with or without condom use.
    • c. importance of safer drug use equipment.
  • 13. The first prescription for FTC/TDF in the PrEP-RN model is for
    • a. 1 month.
    • b. 2 months.
    • c. 3 months.
  • 14. According to the eGFR management pathway for the 1st visit, if the eGFR is <60 mL/min and the last sexual contact (LSC) was >3 days ago, what is the next step?
    • a. If the LSC was high risk, page infectious diseases practitioner on-call for referral in <24 hours.
    • b. Prescribe FTC/TDF.
    • c. No action is indicated.
  • 15. Side effects from FTC/TDF include
    • a. dry mouth.
    • b. insomnia.
    • c. bloating.
  • 16. After the initial prescription, patients who follow the PrEP-RN program have clinic visits every
    • a. month.
    • b. 3 months.
    • c. 6 months.
  • 17. In the PrEP-RN model at the clinic described in this article, how long are services provided before patients are referred to an external provider for continuation of care?
    • a. 6 to 12 months
    • b. 14 to 16 months
    • c. 18 to 24 months
  • 18. Research by O’Byrne, et al. (2017) revealed that a total of how many patients who completed a single course of PEP went on to acquire HIV within 12 months due to a new exposure to HIV not treated with PEP?
    • a. 9%
    • b. 12%
    • c. 15%
© 2019 Association of Nurses in AIDS Care